Clinical trial
Long-Term Efficacy in AMD of Rheopheresis in North America
NCT00380172 · OccuLogix, Industry · Unknown status
Key facts
| NCT number | NCT00380172 |
|---|---|
| Title | Long-Term Efficacy in AMD of Rheopheresis in North America |
| Official title | A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months) |
| Lead sponsor | OccuLogix, Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Device |
| Interventions | Rheopheresis blood filtration |
| Enrollment | 120 |
| Start date | Oct 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Sep 25, 2006 |
| Last update posted | Sep 25, 2006 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: